U.S. hemp bill clarifies what counts as “industrial hemp” — and why that matters for Australia

A small but consequential piece of legislation buried in the U.S. budget bill has given America’s hemp industry a jolt. In the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (H.R. 5371), Congress has included “Industrial Hemp Provisions” in Title VIIlocalhost. Though hardly headline-grabbing, these provisions redraw the line between industrial hemp (fibre and grain) and cannabinoid-rich hemp used for CBD and other intoxicating derivatives.

What the new law does

According to U.S. stakeholders, the law closes a loophole that previously allowed growers of “industrial hemp” to convert harvests into psychoactive derivatives. In a LinkedIn post, Hempitecture CEO Mattie Mead writes that the bill “will have a positive impact on businesses working with fibre and grain hemp” because it formally distinguishes three very different cultivation systems:

• Fibre hemp – planted densely for tall stalks, used in textiles, insulation and biocomposites;
  
• Grain hemp – bred for seed and food products;
  
• CBD or cannabinoid hemp – spaced out to maximise flower content for cannabinoid extraction.
  

By clarifying these categories, Mead argues, U.S. regulators are finally recognising that industrial hemp should not be regulated in the same way as hemp grown for intoxicating compounds. He also notes that companies like his still face burdensome background checks and licensing requirements, even though they grow hemp more like a conventional crop, and hopes this change helps “move us closer to being recognised as an agricultural industry with enormous potential.”

IND HEMP CEO Morgan Tweet took a similar stance, telling followers that the bill does not negatively affect industrial hemp grown for grain or fibre. Tweet said her company has been working with the National Hemp Association to build a “durable, science-based regulatory framework” that distinguishes agricultural hemp from cannabinoid production. While sympathising with CBD businesses caught off guard, IND HEMP emphasised that clear regulation is essential for investment and for farmers’ confidence. The new language, she said, is an important step toward stability and long-term growth.

Both IND HEMP and Hempitecture are leading the way in the United States, demonstrating integrity, vision, and collaboration in a time of major transition. At Margaret River Hemp Co, we have the utmost respect for their leadership — and for the clarity they’re helping to bring to a rapidly evolving industry.

Winners and losers

For U.S. builders, food processors and fibre innovators, the news is welcome. It means less regulatory uncertainty and less risk of their investments being lumped together with a federally contested cannabinoid market. Mead notes that industrial hemp has “nothing to do with intoxicating substances” and that the shift could finally decouple industrial hemp from cannabis prohibition.

However, the law could have painful implications for small CBD producers. Companies that relied on the previous ambiguity to convert hemp into psychoactive cannabinoids (often labelled “delta‑8 THC”) may see their operations curtailed. Both Mead and Tweet acknowledge that farmers and businesses in the cannabinoid space have real investments and livelihoods at stake. Without careful transition measures, some may be forced out of business.

What it means for Australia

From an Australian perspective, the debate highlights how far ahead our regulatory framework already is. In Australia, hemp for food and fibre is regulated separately from medicinal cannabis and CBD. Farmers growing hemp for seed or fibre need licences, but they do not face the same restrictions as medicinal cannabis cultivators; THC limits for industrial hemp are set at 1.0 % or lower (state-dependent), and strict testing ensures compliance. Cannabinoid products, by contrast, are handled under the Therapeutic Goods Administration and require separate approvals.

That clear separation has allowed Australia’s hemp industry to develop a reliable supply chain for building materials, hemp foods and textiles without the confusion that still lingers in the U.S. For example, hempcrete builders and hemp seed processors here don’t share regulatory space with CBD oil producers. The U.S. reforms are essentially catching up with that model. As Hempitecture and IND HEMP have argued, industrial hemp will now be treated more like corn, soybeans or wool — a mainstream agricultural commodity rather than a pseudo‑drug crop.

The shift may also strengthen global confidence in hemp as a climate‑positive crop. In Australia, industrial hemp has been championed as a rotational crop that sequesters carbon, revitalises soils and produces low‑carbon building materials. By removing regulatory confusion in the U.S., the new law could unlock similar gains there.

A note of caution

Yet the situation also serves as a cautionary tale. Loosely defined legislation can open loopholes, allow bad actors to dominate a market, and invite backlash that hurts legitimate businesses. While the U.S. hemp/cannabinoid boom created opportunities, it also blurred the line between hemp and marijuana, feeding public and political concerns. Australia’s industry leaders should continue advocating for distinct pathways for fibre, grain and medicinal products and ensure state laws remain harmonised. Consistency and clarity in regulation are critical to avoid the “wild west” scenario some U.S. commentators now lament.

Looking ahead

The House bill is just the beginning. Supporters of industrial hemp in the U.S. hope the next Farm Bill will include certified seed programs, regionally adapted breeding and uniform THC testing rules. Morgan Tweet’s ad‑hoc coalition aims to push for these structural reforms. Meanwhile, CBD businesses will likely lobby for transitional measures or alternative pathways so they aren’t left in the cold.

For the Australian hemp industry, the takeaway is twofold: celebrate the clarity that helps your U.S. colleagues — many of whom are partners in research or supply chains — and continue to press for policies that differentiate between hemp uses. By doing so, we can support small businesses on both sides of the Pacific while ensuring hemp’s many benefits remain accessible and free from stigma.Citation: The U.S. bill’s table of contents lists the “Industrial Hemp Provisions” under Title VIIlocalhost, confirming Congress embedded hemp reforms in the 2026 appropriations act.